Analysis of Medicare Prescription Drug Plans In 2012 And Key Trends Since 2006
This report presents findings from an analysis of the Medicare Part D marketplace in 2012 and changes in drug coverage and costs since 2006.
View the Latest: Prescription Drugs
Filter
-
-
Transparency and Complexity
PerspectiveThis fall a new rule takes effect requiring all private health plans to offer a uniform, simple to read, summary of benefits and coverage (SBC). The SBC will provide consumers with standardized information about how plans cover essential health benefits and what coverage limits and cost sharing applies.
-
The Part D Experience: What are the Lessons for Broader Medicare Reform?
Event Date:EventLaunched in 2006, Medicare added a prescription drug benefit that relies entirely on private plans, while, for other benefits, beneficiaries have a choice between private health plans and traditional fee-for-service Medicare.
-
Prescription Drug Procurement and the Federal Budget
Issue BriefThis brief commissioned by the Foundation considers areas where Medicare faces limited opportunity for market-based competition and price negotiation to drive down drug spending.
-
Medicare Part D Spending Trends: Understanding Key Drivers and the Role of Competition
Issue BriefThis brief commissioned by the Foundation examines factors that contributed to Medicare's lower-than-expected spending on prescription drugs under the Medicare Part D drug benefit that started in 2006. Since its launch, Medicare has spent about 30 percent less on Part D benefits than the Congressional Budget Office originally projected.
-
Pharmaceutical Policy and Pricing: Are Other Countries Getting Greater Value?
Event Date:EventSpending on prescription drugs in the U.S. rose at a faster clip in 2009 than spending for hospital and physician care, a trend that is expected to continue through 2020. The desire to get a handle on drug spending is a focus not only in the U.S. but in other countries as well.
-
Medicare Part D 2011 Data Spotlights
ReportThe Kaiser Family Foundation has issued a collection of analyses related to the Medicare Part D stand-alone drug plan options available to seniors for calendar year 2011. These spotlights focuses on key aspects of the drug plan choices available and relevant trends since the Medicare drug benefit took effect in 2006.
-
Medicare Part D Data Spotlight: A First Look at Part D Plan Offerings in 2012
ReportThis data spotlight examines the stand-alone Part D drug plan options available to Medicare beneficiaries in 2012. Medicare beneficiaries will, on average, be able to choose from 31 stand-alone Medicare Part D prescription drug plans to choose from, a new Kaiser analysis finds.
-
Analysis of Medicare Prescription Drug Plans in 2011 and Key Trends Since 2006
ReportThis report presents findings from an analysis of the Medicare Part D marketplace in 2011 and changes in drug coverage and costs since 2006.
-
Medicare Part D 2011 Data Spotlight: The Coverage Gap
ReportThis data spotlight examines the availability of gap coverage in the private Medicare Part D drug plans offered to beneficiaries in 2011, the first year of the phase-out of the gap, as required under the 2010 health reform law.